Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
9.76
+0.18 (1.88%)
Jan 16, 2026, 3:11 PM EST - Market open
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $554.72 million as of January 16, 2026. Its market cap has increased by 10.70% in one year.
Market Cap
554.72M
Enterprise Value
520.65M
1-Year Change
10.70%
Ranking
Category
Stock Price
$9.76
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $554.72M, a decrease of -74.58%. That is a compound annual growth rate of -25.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 544.49M | 15.28% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | 2.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |